Ultralife (ULBI) to Take $2.7M Q1 Charge; Updates FY11 Outlook
Tweet
Share
E-mailGet Alerts ULBI Hot Sheet
Price: $7.01 +2.34%
Financial Fact:
Net income (loss): 1.02M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net income (loss): 1.02M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Ultralife Corporation (Nasdaq: ULBI) reports that it plans to take a $2.7 million charge, which will be recorded on its Q111 results.
The charge will be taken to reflect a proposed settlement with the U.S. government related to three exigent contracts that were completed between 2003 and 2004.
Ultralife now sees FY11 revs of about $165 million and net income of $7.8 million. Consensus is looking for revs of $180.47 million.
The charge will be taken to reflect a proposed settlement with the U.S. government related to three exigent contracts that were completed between 2003 and 2004.
Ultralife now sees FY11 revs of about $165 million and net income of $7.8 million. Consensus is looking for revs of $180.47 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- enVVeno Medical (NVNO) files $100M mixed shelf
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
Create E-mail Alert Related Categories
Corporate News, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
